Depelestat

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameDepelestat
Drug Alias NameReltranEngineered protein inhibitor of human neutrophil elastaseDebio-9701DX-890
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLeukocyte elastase inhibitors
TargetsLeukocyte elastase
Therapy Area/IndicationsInflammationFibrosisRespiration Disorders +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTunisiaItalyFrance +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDyax Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDebiopharm International Sa
Active IndicationsN/A
Inactive IndicationsInflammationFibrosisRespiration Disorders +[6] 

Other Information

ATC CodeN/A
Related LinksN/A